Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

SIMPLE SUMMARY: Timely execution and reporting of cancer clinical trials is important to patients and clinical researchers. Looking at a group of over three hundred cancer clinical trials with published results, we studied what factors influenced how quickly they reported their results in scientific...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Timothy A., Fuller, Clifton David, Verma, Vivek, Mainwaring, Walker, Espinoza, Andres F., Miller, Austin B., Jethanandani, Amit, Pasalic, Dario, Das, Prajnan, Minsky, Bruce D., Thomas, Charles R., Fogelman, David R., Subbiah, Vivek, Subbiah, Ishwaria M., Ludmir, Ethan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563891/
https://www.ncbi.nlm.nih.gov/pubmed/32947844
http://dx.doi.org/10.3390/cancers12092636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563891/
https://www.ncbi.nlm.nih.gov/pubmed/32947844
http://dx.doi.org/10.3390/cancers12092636

Ejemplares similares